PCK1 and pancreatic neoplasm: In the primary pancreatic cancer cells derived from three patients, pPC1/pPC2/pPC3, the application of the lentiviral PCK1 shRNA (Seq1) led to robust PCK1 mRNA silencing (Fig. 2J).